CUVIA Inc. Information

CUVIA develops and manufactures recombinant proteins and peptides for biopharmaceutical research and manufacturing. We bring protein design, host biology, process development, manufacturing, and application together under one roof. Rather than developing a molecule first and asking how to manufacture it later, we design the product and the process together, with scale, quality, cost and the application already in mind. All products are made in-house in the USA. Evaluation samples are ready for four product categories today: ● Antibody processing: ZetaCapture, an engineered Protein A ligand, and IdeS ● Growth factors: human EGF, with human insulin in qualification ● Nucleases: Serratia and micrococcal nucleases ● Fluorescent proteins: a suite spanning the visible spectrum Every product is characterized before it is sold, and every value we report travels with the conditions it was measured under. Product data and evaluation material are available on request, so you can test performance in your own format. We have a broad pipeline. Talk to us about adding your molecule to our pipeline. CUVIA is a venture-backed biotechnology company with investment from GV, Alphabet's independent venture capital firm. We are based in Mountain View, California.